Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Why hydroxychloroquine takes months to work and months to leave the body—and how its unusual pharmacokinetics shape dosing in lupus and rheumatoid arthritis.
Hydroxychloroquine can slowly damage the retina after years of use. Here's what the evidence shows about who is most at risk and why regular eye exams matter.
Hydroxychloroquine and praziquantel are unrelated drugs treating unrelated conditions. This article explains their distinct mechanisms, approved uses, and why comparing them directly is usually a category error.
Hydroxychloroquine and mebendazole treat entirely different conditions through unrelated mechanisms. Here is how each actually works, and what to know if both appear on the same medicine cabinet shelf.
Hydroxychloroquine and doxycycline are unrelated drugs from different classes, occasionally confused because both appear in malaria and infection care.
Hydroxychloroquine dosing is calculated from actual body weight, not a flat number, because the drug accumulates in tissue over years and can harm the retina.
Hydroxychloroquine calms an overactive immune system by altering cell chemistry at the molecular level—explaining its real, proven roles and its limits.
Two long-established drugs from entirely different families, briefly paired in the headlines. Here is what each actually does, and why combining them requires real medical caution.
A close look at what clinical evidence actually shows about hydroxychloroquine use in children, during pregnancy and breastfeeding, and in older adults.